Annual Report

The report describes Novartis's 2010 access-to-medicine programs, which reached 85.5 million patients and had a reported value of USD 1 544 million. It also reports 119 418 full-time equivalent positions at year-end including Alcon, and states that sales-force fleet emissions were reduced by 14%, exceeding the initial target.